Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

Sanofi moves to replace Medivation board

Sanofi moves to replace Medivation board Sanofi is seeking to remove and replace Medivation's eight member board of directors in an attempt to gain control of the US firm - and its prize prostate cancer therapy, Xtandi ... Medivation's advanced castration-resistant prostate cancer blockbuster

Deal Watch May 2016

Deal Watch May 2016 The prize of course is the one marketed product in Medivation's portfolio, Xtandi [enzalutamide for the treatment of advanced prostate cancer] with sales estimated to reach $1.5bn and already

Deal Watch March 2016

Deal Watch March 2016 Only one other deal had an upfront value of more than $1bn: the sale by UCLA to Royalty Pharma of its royalty rights to Xtandi with a cash payment of ... Research collaboration. $2, 258. UCLA/ Royalty Pharma. Xtandi – androgen receptor inhibitor.

Sanofi hints at sweetened Medivation deal - or hostile bid

Sanofi hints at sweetened Medivation deal - or hostile bid The letter comes as Medivation reported its first-quarter results, headlined by a 53% increase in sales of its only marketed drug - prostate cancer therapy Xtandi (enzalutamide) - to $547m compared to ... The company also reiterated its financial

Medivation unimpressed with Sanofi's offer

Medivation unimpressed with Sanofi's offer Sanofi is keen to get hold of Medivation for its fast-growing prostate cancer drug Xtandi (enzalutamide) - which made $1.9bn in sales last year and is growing at a phenomenal ... The offer has come ahead of the scheduled review date for Medivation's

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics